Maxigesic approval positive for AFT Pharmaceuticals

Maxigesic approval positive for AFT Pharmaceuticals
AFT founder and managing director Hartley Atkinson. (Image: Supplied)
Tamara Poi-Ngawhika
 AFT Pharmaceuticals, the owner of Maxigesic, offers investors a “large opportunity but with a high degree of uncertainty”, according to Forsyth Barr analysts.The New Zealand stock exchange-listed company has just announced its rapid-release tablet form of Maxigesic has been granted approval by the United States Food and Drug Administration (FDA) for use in the country.Breaking into the US market is difficult because getting FDA approval can be challenging. AFT said the US market is worth about US$7.16 billion (NZ$11.5b) and is...

More Markets

NZ sharemarket down 0.1%, but AIA up 11c
Markets Market Close

NZ sharemarket down 0.1%, but AIA up 11c

The S&P/NZX 50 Index closed at 12,270, down 17.46 points or 0.14%.

Graham Skellern 31 Mar 2025
Fletcher Building’s Clever Core prefab house-building factory to shut
Property

Fletcher Building’s Clever Core prefab house-building factory to shut

Fletcher Building’s much-vaunted Clever Core prefab house-building factory at Wiri in South Auckland will close next year and be replaced by a PlaceMakers frame and truss plant.A spokeswoman said Clever Core had not worked out and would close by June 30.“Fletcher Building has mad...

Staff reporters 31 Mar 2025
NZME delay shows the company is out of ideas: Grenon
Markets

NZME delay shows the company is out of ideas: Grenon

"That's really the best move they've got, isn't it?" Jim Grenon says.

NZME board drama: shareholder showdown delayed
Markets

NZME board drama: shareholder showdown delayed

NZME says crunch governance meeting will now be in June after it received legal advice.